Ojaswita, presently develops content for page125.org and a number of other similar platforms. Endowed with a prior experience of being a Technical Engineer, she now writes articles pertaining to business trends and the latest industry news. That apart, she loves to listen to music, craft, and cook in her leisure time. She can be contacted at- [email protected] | https://twitter.com/ojaswita_k
These digital devices are the basis of Cognoa’s precision health platform. The FDA Breakthrough Device Program is envisioned to help patients in receiving timely access to advance technologies. Cognoa, Inc., the developer of AI-based personalized therapies and digital diagnostics, has reportedly announced that its first …
The latest takeover is in line with the strategy of Resonetics to add new manufacturing abilities. The financial terms of the acquisition are yet to be disclosed. The US-based laser micro manufacturing services provider Resonetics has reportedly purchased the contract medical device maker Caribou …
Pharmaceutical company Lupin has apparently launched the generic version of Clomipramine Hydrochloride capsules in the United States. Credible reports cite that these capsules have been introduced in the strengths of 25 mg, 50 mg, and 75 mg in the U.S. market. As per sources familiar …
The funding has been allotted by NASA Nebraska Space Grant, one of the 52 space grant consortiums in the U.S. Copper 3D, the Chilean/USA based 3D printing industry leader, has made it to the headlines for receiving a new grant from NASA. Reportedly, the Copper …
Senseonics Holdings, Inc., a US-based medical technology company, has reportedly announced the extension of its distribution agreement with Roche Diabetes Care based in Indianapolis, USA. The agreement has now been extended up to 31st of January 2021. As per the extended agreement, Senseonics will continue …
The latest transaction is the second significant collaboration by the two companies MeiraGTx Holdings Plc, a clinical-stage gene therapy company, has reportedly inked a strategic collaboration agreement with Janssen Pharmaceuticals, Inc., in a bid to develop and commercialize gene therapies for the IRD (inherited retinal …
Fexinidazole would add to the global efforts dedicated to eliminating sleeping sickness, a deadly neglected tropical disease, by 2020. The Democratic Republic of Congo exhibits the maximum incidence rate of sleeping sickness disease, with approximately 85 percent of recorded incidences. The Democratic Republic of Congo …
The investment round saw the participation of Hudson Park Capital, PLH Business Ventures, ATX Seed Ventures, and several other industry veterans. CherryCircles’ software lets the pharma companies to capture development knowledge over time and handle risk across numerous dimensions with data. The US-based CherryCircle Software, …
IllumiCare’s Smart Ribbon technology is currently live across more than 120 hospitals in the U.S. OptimizeRx Corp., one of the most prominent provider of digital health messaging for the pharma industry, has declared that it has established a new partnership with IllumiCare. The agreement entails …